CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

379 hedge funds and large institutions have $2.54B invested in CRISPR Therapeutics in 2023 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 102 increasing their positions, 120 reducing their positions, and 57 closing their positions.

Holders
379
Holders Change
-16
Holders Change %
-4.05%
% of All Funds
6.07%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
48
Increased
102
Reduced
120
Closed
57
Calls
$79.7M
Puts
$71.8M
Net Calls
+$7.92M
Net Calls Change
-$15.3M

Top Buyers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$166M
2
Capital International Investors
2
Capital International Investors
California
$272M
3
Millennium Management
3
Millennium Management
New York
$10.4M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$13.4M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$9.77M

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$22.4M
2
Goldman Sachs
2
Goldman Sachs
New York
$10.7M
3
PI
3
PEAK6 Investments
Illinois
$2.26M
4
AC
4
Armistice Capital
New York
$37.3M
5
UBS Group
5
UBS Group
Switzerland
$11.1M
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$361M 7,990,188 +160,256 +2%
Capital International Investors
2
Capital International Investors
California
$272M 6,023,638 +669,088 +12%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$180M 3,973,180 -33,296 -0.8%
NAMA
4
Nikko Asset Management Americas
New York
$179M 3,972,139 -34,337 -0.9%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$166M 3,664,371 +670,794 +22%
BlackRock
6
BlackRock
New York
$127M 2,798,581 +168,844 +6%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$96.7M 2,139,056 -45,328 -2%
State Street
8
State Street
Massachusetts
$89.8M 1,986,187 -94,929 -5%
NMC
9
NEA Management Company
Maryland
$71.8M 1,587,854 – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$67.1M 1,484,569 +42,292 +3%
Loomis, Sayles & Company
11
Loomis, Sayles & Company
Massachusetts
$52.3M 1,156,810 -31,511 -3%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$49.9M 1,102,721 -20,127 -2%
BG
13
Bellevue Group
Switzerland
$40.7M 899,800 -11,905 -1%
CS
14
Credit Suisse
Switzerland
$38.3M 847,273 -5,616 -0.7%
AC
15
Armistice Capital
New York
$37.3M 824,000 -212,000 -20%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$36.6M 809,984 +20,886 +3%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$34.4M 759,735 -15,076 -2%
Charles Schwab
18
Charles Schwab
California
$29M 640,777 -317 -0%
Norges Bank
19
Norges Bank
Norway
$28.5M 629,652 -85,776 -12%
JPMorgan Chase & Co
20
JPMorgan Chase & Co
New York
$26.4M 582,664 -6,959 -1%
Bank of America
21
Bank of America
North Carolina
$23.4M 517,706 +91,190 +21%
Federated Hermes
22
Federated Hermes
Pennsylvania
$23M 508,758 – –
VVM
23
Versant Venture Management
California
$22.5M 498,558 – –
Renaissance Technologies
24
Renaissance Technologies
New York
$22.4M 495,103 -291,497 -37%
Morgan Stanley
25
Morgan Stanley
New York
$21.3M 470,526 -37,267 -7%
1
2 3 4 5